Article
Mountain View, CA-Add Mississippi to the list of states whose Medicare administrators will pay for transpupillary thermother-apy (TTT) treatment of wet age-related macular degeneration (AMD).
FDA accepts new drug application for low-dose atropine from Sydnexis
Commercial real estate and your practice, part two with Colin Carr
AI and eye tracking: Technological companions to assess amblyopia in pediatric patients
Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
Study highlights strong parental cooperation in preschool vision screening
Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children